The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog is intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at www.Vicus.com, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Support this site

    If you found the information here helpful, please consider supporting this site.If you found the information here helpful, please consider supporting this site.

  • Recent Posts

  • Recent Comments

    A contrarian’s view of lycopene and prostate cancer

    Despite the fact that it’s widely believed that lycopene protects against prostate cancer, Dr. Ulrike Peters at the Fred Hutchinson Cancer Research Center in Seattle says “studies of the potentially protective role of lycopene have been contradictory or inconclusive.”

    Here are two studies that support her skepticism.

    In 2006, she and her colleagues evaluated the association between lycopene intake and specific tomato products and the risk of cancer of the prostate and other cancers in almost 30,000 men followed for over 4 years.

    The results did not support the hypothesis that greater lycopene/tomato product consumption protects from prostate cancer.

    Now, the results of another study in over 28,000 men compared blood levels of lycopene and the risk of prostate cancer.

    • Men were screened using a PSA (prostate specific antigen) test and digital rectal exam.
    • They were followed until the first occurrence of prostate cancer, death, or the end of the trial between one to 8 years later.
    • The researchers focused on non-Hispanic Caucasian men.

    And the results.

    • There was no significant difference between those who developed prostate cancer and those who did not and their blood concentrations of lycopene.

    The bottom line?
    Here’s a review that discusses studies prior to 2004 where an association between lycopene and prostate cancer was noticed.

    Perhaps as researchers use prospective studies to hone in on the lycopene:prostate cancer relationship the associations reported in earlier surveys and retrospective studies are not holding up.

    5/21/07 22:27 JR

    Leave a Comment

    You must be logged in to post a comment.